REVSColumbia Research Enhanced Value ETF
Seeks investment results that closely correspond to the performance of the Beta Advantage Research Enhanced U.S. Value Index.
By Columbia Threadneedle · Launched 2019
Annual Cost
0.19%
#957 of 5,562 · low cost
Fund Size
$304M
#1,942 of 5,562 · mid-size
Return (1Y)Goal
+26.6%
Track Record
6 years
#1,964 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$12,638+26.4%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Index enhanced
Factor
Value
Index tracked
Beta Advantage Research Enhanced US Value Index
What it actually holds
By weightConcentration
Top 10 holdings = 27.6% of fund✓ well diversified
Wells Fargo & Co
3.8%
Procter & Gamble Co/The
3.6%
Exxon Mobil Corp
3.3%
Alphabet Inc
3.0%
Cisco Systems Inc
2.7%
Alphabet Inc
2.4%
Pfizer Inc
2.3%
Citigroup Inc
2.2%
S&P Global Inc
2.1%
Charles Schwab Corp/The
2.1%
Asset allocation
Stocks
99.4%
Cash
0.6%
By sector
Financial Services
18.3%
Technology
16.4%
Industrials
11.8%
Healthcare
11.4%
Communication
8.3%
Consumer Cyclical
7.7%
Consumer Defensive
6.8%
Energy
6.7%
Other
12.6%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
11.5%Moderate
Year-on-year price swings
Max drawdown
-37.9%Severe
Worst peak-to-trough loss
Sharpe (3Y)
1.04Strong risk-adjusted returns
Sortino (3Y)
1.52Good downside protection
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks investment results that closely correspond to the performance of the Beta Advantage Research Enhanced U.S. Value Index.
- Strategy
- Invests at least 80% of assets in securities of the Index, which reflects a rules-based strategic beta approach to U.S. large- and mid-cap value companies. The Fund uses a replication strategy to track the Index's performance, investing in component securities in similar proportions.
- Inception date
- September 25, 2019
- Fund family
- Columbia Threadneedle
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed REVS. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19